Media coverage about Quintiles Transitional Holdings (NYSE:Q) has trended somewhat positive recently, according to Accern. Accern identifies positive and negative news coverage by monitoring more than twenty million news and blog sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to one, with scores closest to one being the most favorable. Quintiles Transitional Holdings earned a news impact score of 0.19 on Accern’s scale. Accern also gave media headlines about the medical research company an impact score of 47.2134949403107 out of 100, meaning that recent news coverage is somewhat unlikely to have an effect on the stock’s share price in the next several days.
These are some of the news stories that may have effected Accern’s analysis:
- Quintiles Transitional Holdings Inc. (NYSE:Q) Posts Earnings Results, Beats Expectations By $0.04 EPS (americanbankingnews.com)
- Quintiles Transitional Holdings’ (Q) “Hold” Rating Reiterated at Stifel Nicolaus (americanbankingnews.com)
- Barclays PLC Increases Quintiles Transitional Holdings Inc. (NYSE:Q) Price Target to $100.00 (americanbankingnews.com)
- QuintilesIMS Reports Second-Quarter 2017 Results | Business Wire - Business Wire (press release) (businesswire.com)
- Edited Transcript of Q.N earnings conference call or presentation 3-Aug-17 1:00pm GMT (finance.yahoo.com)
Quintiles Transitional Holdings (Q) traded down 0.75% during trading on Friday, reaching $90.42. The company’s stock had a trading volume of 1,263,883 shares. The company has a market capitalization of $19.90 billion, a P/E ratio of 200.04 and a beta of 0.64. Quintiles Transitional Holdings has a 12-month low of $70.10 and a 12-month high of $93.53. The firm’s 50-day moving average price is $89.50 and its 200 day moving average price is $82.85.
Quintiles Transitional Holdings (NYSE:Q) last posted its quarterly earnings results on Thursday, August 3rd. The medical research company reported $1.09 earnings per share for the quarter, beating the Thomson Reuters’ consensus estimate of $1.05 by $0.04. The business had revenue of $1.97 billion for the quarter, compared to the consensus estimate of $1.96 billion. Quintiles Transitional Holdings had a return on equity of 15.68% and a net margin of 0.82%. The company’s quarterly revenue was up 68.7% compared to the same quarter last year. During the same quarter in the previous year, the business earned $0.93 EPS. On average, analysts predict that Quintiles Transitional Holdings will post $4.55 earnings per share for the current fiscal year.
Quintiles Transitional Holdings announced that its board has authorized a stock buyback plan on Wednesday, May 24th that permits the company to buyback $1.00 billion in outstanding shares. This buyback authorization permits the medical research company to reacquire up to 5.4% of its stock through open market purchases. Stock buyback plans are generally an indication that the company’s board believes its shares are undervalued.
A number of equities analysts recently commented on the company. Barclays PLC upped their target price on Quintiles Transitional Holdings from $98.00 to $100.00 and gave the company an “overweight” rating in a report on Friday. Zacks Investment Research downgraded Quintiles Transitional Holdings from a “buy” rating to a “hold” rating in a report on Tuesday. Jefferies Group LLC restated a “hold” rating and set a $94.00 target price on shares of Quintiles Transitional Holdings in a report on Friday. Stifel Nicolaus restated a “hold” rating and set a $92.00 target price on shares of Quintiles Transitional Holdings in a report on Friday. Finally, William Blair upgraded Quintiles Transitional Holdings from a “market perform” rating to an “outperform” rating and upped their target price for the company from $70.10 to $93.42 in a report on Friday. Eleven investment analysts have rated the stock with a hold rating and nine have issued a buy rating to the stock. Quintiles Transitional Holdings presently has an average rating of “Hold” and an average price target of $89.88.
ILLEGAL ACTIVITY NOTICE: “Somewhat Positive Press Coverage Somewhat Unlikely to Affect Quintiles Transitional Holdings (Q) Stock Price” was posted by StockNewsTimes and is owned by of StockNewsTimes. If you are viewing this report on another website, it was illegally copied and republished in violation of US and international copyright & trademark laws. The original version of this report can be accessed at https://stocknewstimes.com/2017/08/05/somewhat-positive-press-coverage-somewhat-unlikely-to-affect-quintiles-transitional-holdings-q-stock-price.html.
In other Quintiles Transitional Holdings news, Director John G. Danhakl sold 761,143 shares of the business’s stock in a transaction dated Tuesday, May 30th. The stock was sold at an average price of $84.01, for a total transaction of $63,943,623.43. The transaction was disclosed in a filing with the SEC, which is accessible through this hyperlink. Also, Director Jack M. Greenberg sold 6,092 shares of the business’s stock in a transaction dated Wednesday, May 17th. The shares were sold at an average price of $82.50, for a total value of $502,590.00. Following the sale, the director now owns 2,930 shares in the company, valued at approximately $241,725. The disclosure for this sale can be found here. In the last quarter, insiders have sold 8,758,400 shares of company stock worth $735,783,985. Company insiders own 6.40% of the company’s stock.
About Quintiles Transitional Holdings
Quintiles IMS Holdings, Inc, formerly Quintiles Transnational Holdings Inc, provides integrated information and technology-enabled healthcare services. The Company operates through segments, including Commercial Solutions; Research & Development Solutions, and Integrated Engagement Services. The Commercial Solutions segment offerings include national information offerings, sub-national information offerings, technology solutions, and workflow analytics and consulting services.
Receive News & Ratings for Quintiles Transitional Holdings Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Quintiles Transitional Holdings Inc. and related companies with MarketBeat.com's FREE daily email newsletter.
